Contact Liz Dowling, 415-388-2794
Dowling & Dennis Public Relations
Media Backgrounder: Better Care by Reducing Blood Culture Contamination: Sepsis, SteriPath and Antimicrobial Stewardship
Media Backgrounder: Study by Mark Rupp, M.D. in Clinical Infectious Diseases: Reduction in Blood Culture Contamination Through Use of Initial Specimen Diversion Device (SteriPath)
Contact us now to discuss a zero-risk SteriPath evaluation for your hospital.
For more information about Magnolia Medical and the SteriPath System, please fill out the form below.
We will get in touch with you as soon as we can.
For more information about a zero-risk SteriPath evaluation,
complete the form below.
A representative with Magnolia Medical Technologies will contact you within 24 hours.